Ardelyx (ARDX) Operating Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 1,433.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,433.00 |
| Dec 31, 2025 | -292.00 |
| Sep 30, 2025 | 13,502.00 |
| Jun 30, 2025 | 388.00 |
| Mar 31, 2025 | 458.00 |
| Dec 31, 2024 | 8,844.00 |
| Sep 30, 2024 | -1,085.00 |
| Jun 30, 2024 | 5,582.00 |
| Mar 31, 2024 | 17,563.00 |
| Dec 31, 2023 | -10,893.00 |
| Sep 30, 2023 | 45,195.00 |
| Jun 30, 2023 | 96,337.00 |
| Mar 31, 2023 | 571,241.00 |
| Dec 31, 2022 | 345,538.00 |
| Sep 30, 2022 | 316,185.00 |
| Jun 30, 2022 | 237,666.00 |
| Mar 31, 2022 | -545,542.00 |
| Dec 31, 2021 | -189,981.00 |
| Sep 30, 2021 | -296,814.00 |
| Jun 30, 2021 | -209,601.00 |
| Mar 31, 2021 | 130,839.00 |
| Dec 31, 2020 | -69,039.00 |
| Sep 30, 2020 | 10,058.00 |
| Jun 30, 2020 | 13.66 Mn |
| Dec 31, 2019 | 3.14 Mn |
| Sep 30, 2019 | 1.31 Mn |
| Jun 30, 2019 | -6.41 Mn |
| Jun 30, 2015 | 1,981.00 |
| Mar 31, 2015 | -5,390.00 |
| Dec 31, 2014 | -5,360.00 |
| Sep 30, 2014 | 1,450.00 |
| Jun 30, 2014 | 4,178.00 |